Grand Medical Group

About us

Grand Medical Group AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

read more

10 Kornmarkt Street, CH - 6004 Luzern, Switzerland

info@grandmedicalgroup.ch

+41 415880810

Each ?lm-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine, ?56

PHARMACOLOGIC PROPERTIES

ATC code: N06DX01, Psychoanaleptics. Other Anti-dementia drugs There is increasing evidence that malfunctioning of glutamatergic neurotransmission, in particular at NMDA- receptors, contributes to both expression of symptoms and disease progression in neurodegenerative dementia. Memantine is a voltage-dependent, moderate- a?nity uncompetitive NMDA-receptor antagonist. It modulates the e?ects of pathologically elevated tonic levels of glutamate that may lead to neuronal dysfunction.

THERAPEUTIC INDICATIONS

NERMONT is indicated for the treatment of adult patients with moderate to severe Alzheimer’s disease.

LEAFLETS